CLINICAL_TRIALS
trial_result
· 2014-04-02
Clinical Trial Update: Phase 3 Study of Sofosbuvir and Ribavirin [Phase 3]
Summary
A Phase 3 study evaluating the combination of Sofosbuvir and Ribavirin for Hepatitis C has completed. Results were posted in April 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED | Results posted: 2014-04-02